Leqembi approval offers renewed hope for novel Alzheimer's disease treatments
US officials have granted full approval to Leqembi, the first medication to demonstrate modest effectiveness in slowing cognitive decline associated with...
Stay updated with breaking news from Life Sciences Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
US officials have granted full approval to Leqembi, the first medication to demonstrate modest effectiveness in slowing cognitive decline associated with...
Raymond James started coverage on shares of Wave Life Sciences (NASDAQ:WVE – Free Report) in a research report released on Wednesday, MarketBeat.com reports. The brokerage issued an outperform rating and a $7.00 price target on the stock. Several other equities research analysts have also recently commented on WVE. Jefferies Financial Group cut shares of Wave […]
Equities research analysts at Raymond James assumed coverage on shares of Wave Life Sciences (NASDAQ:WVE – Free Report) in a note issued to investors on Wednesday, MarketBeat.com reports. The firm set an “outperform” rating and a $7.00 price target on the stock. Raymond James’ price target indicates a potential upside of 83.73% from the stock’s […]
Raymond James has initiated coverage on WAVE Life Sciences Ltd (NASDAQ: WVE) with a price target of $9 and
SPC Life Sciences has received approval from the Securities and Exchange Board of India (Sebi) to raise funds through an initial public offering (IPO). The IPO will consist of fresh equity shares worth Rs 300 crore and an Offer For Sale of 89.39 lakh equity shares by the company's promoter. The company may also consider a pre-IPO placement of up to Rs 60 crore. Proceeds from the IPO will be used to pay debt, support working capital needs, fund capital expenditure, and expand product offerings.